Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

Summary

The Objective of this study is to investigate the long-term efficacy of intranasal oxytocin in improvement of symptoms in patients with schizophrenia who have residual symptoms dispute being on adequate treatment with antipsychotic medication.

Timeline

Start

2012-03

Primary completion

2014-12

Completion

2014-12

Outcome

Outcome not reported

Stopped (Business): “Break in funding”

Drugs

Indications